STAT reports that the Trump administration has taken WuXi AppTec off its list of Chinese military companies operating in the US. WuXi AppTec is an important partner for many pharmaceutical companies.
This change reduces some regulatory and geopolitical risk for pharma firms that rely on WuXi for research or manufacturing. However, companies should remain alert for further changes in US policy that could affect global supply chains or cross-border partnerships.
